NO982141L - Glial cellelinje avledede neurotrofiske faktorreseptorer - Google Patents
Glial cellelinje avledede neurotrofiske faktorreseptorerInfo
- Publication number
- NO982141L NO982141L NO982141A NO982141A NO982141L NO 982141 L NO982141 L NO 982141L NO 982141 A NO982141 A NO 982141A NO 982141 A NO982141 A NO 982141A NO 982141 L NO982141 L NO 982141L
- Authority
- NO
- Norway
- Prior art keywords
- cell line
- neurotrophic factor
- derived neurotrophic
- glial cell
- factor receptors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Reseptorer for glialcellelinje-avledet neurotrofisk faktor (GDNF), cellulær ekspresjon d-rav, isolering og biokjemisk karakterisering er beskrevet. C-RHT er berkxevet tm cn reseptor for GDNF; og ytterligere nye reseptorer er også beskrevet. Fremstilling av monoklonale antistoffer rettet mot GDNF er også beskrevet.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US661995P | 1995-11-13 | 1995-11-13 | |
US1576796P | 1996-04-16 | 1996-04-16 | |
US2196596P | 1996-06-27 | 1996-06-27 | |
US2063996P | 1996-06-27 | 1996-06-27 | |
US2063896P | 1996-06-27 | 1996-06-27 | |
PCT/US1996/018197 WO1997018240A1 (en) | 1995-11-13 | 1996-11-13 | Glial cell line-derived neurotrophic factor receptors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO982141D0 NO982141D0 (no) | 1998-05-12 |
NO982141L true NO982141L (no) | 1998-07-13 |
Family
ID=27533181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO982141A NO982141L (no) | 1995-11-13 | 1998-05-12 | Glial cellelinje avledede neurotrofiske faktorreseptorer |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0879247A4 (no) |
JP (1) | JP2000501924A (no) |
KR (1) | KR19990067508A (no) |
AU (1) | AU718979B2 (no) |
CA (1) | CA2237641A1 (no) |
NO (1) | NO982141L (no) |
NZ (1) | NZ324511A (no) |
WO (1) | WO1997018240A1 (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6677135B1 (en) | 1996-05-08 | 2004-01-13 | Biogen, Inc. | Ret ligand (RetL) for stimulating neutral and renal growth |
CN1163509C (zh) * | 1996-05-08 | 2004-08-25 | 拜奥根有限公司 | 刺激神经和肾生长的RET配体(RetL) |
US6905817B1 (en) | 1998-10-01 | 2005-06-14 | Licestia Ltd. | Ret-independent signaling pathway for GDNF |
JP2002526775A (ja) * | 1998-10-01 | 2002-08-20 | テイテイエブスキ,アレクセイ・ウラデイミロビチ | GDNFについての新規Ret非依存性シグナリング経路 |
FI20000403A0 (fi) * | 2000-02-22 | 2000-02-22 | Hannu Sariola | GDNF perhesukuisten yhdisteiden käyttö kivessyövän hoitoon tarkoitettujen tuotteiden valmistamiseksi |
IL261666B2 (en) | 2016-03-31 | 2024-09-01 | Ngm Biopharmaceuticals Inc | Related proteins and methods of using them |
-
1996
- 1996-11-13 KR KR1019980703530A patent/KR19990067508A/ko not_active Application Discontinuation
- 1996-11-13 EP EP96942748A patent/EP0879247A4/en not_active Withdrawn
- 1996-11-13 AU AU11588/97A patent/AU718979B2/en not_active Ceased
- 1996-11-13 CA CA002237641A patent/CA2237641A1/en not_active Abandoned
- 1996-11-13 WO PCT/US1996/018197 patent/WO1997018240A1/en not_active Application Discontinuation
- 1996-11-13 JP JP9519039A patent/JP2000501924A/ja not_active Ceased
- 1996-11-13 NZ NZ324511A patent/NZ324511A/en unknown
-
1998
- 1998-05-12 NO NO982141A patent/NO982141L/no unknown
Also Published As
Publication number | Publication date |
---|---|
AU718979B2 (en) | 2000-05-04 |
JP2000501924A (ja) | 2000-02-22 |
WO1997018240A1 (en) | 1997-05-22 |
NO982141D0 (no) | 1998-05-12 |
KR19990067508A (ko) | 1999-08-25 |
AU1158897A (en) | 1997-06-05 |
EP0879247A4 (en) | 2002-01-30 |
NZ324511A (en) | 1999-09-29 |
EP0879247A1 (en) | 1998-11-25 |
CA2237641A1 (en) | 1997-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT72835A (en) | Monoclonal antibodies to rapamicin (derivatives), immunoassay kits for using them, hybridoma cell lines and conjugates containing rapamicin- and protein-part | |
IS1916B (is) | Estrógen gerandefni/mótefni, notkun þeirra og milliefni til framleiðslu þeirra | |
MX9709324A (es) | Compuestos terapeuticos que comprenden anticuerpos anti receptores fc. | |
EP2016953A3 (en) | Vascular endothelial cell growth factor antagonists and uses thereof | |
HUP0000385A2 (hu) | Rádiójel-ismétlő állomás | |
EP1746160A3 (en) | Hepatocyte growth factor receptor antagonists and uses thereof | |
DK1016867T3 (da) | Fremgangsmåde til immunassay af BNP | |
IS2508B (is) | Mótefni gegn ED-B hneppinu í fíbrónektíni, smíði þeirra og notkanir | |
NO982141L (no) | Glial cellelinje avledede neurotrofiske faktorreseptorer | |
JO1927B1 (en) | Olanzapine preparation process | |
NO955314L (no) | Immunoanalyser for opplöselige fibrinpolymerer | |
AU5055593A (en) | Antibodies specific for HIV | |
PT759942E (pt) | Receptor de interleucina-15 | |
ATE279443T1 (de) | A3c6e2, ein monoklonaler antikörper spezifisch für den humanen stammzellfaktor (scf)-rezeptor | |
NO922332D0 (no) | Fremgangsmaate for fremstilling av faktoravhengige, humaneb-cellelinjer | |
ATE143962T1 (de) | Pterinderivate und seine anwendung zur herstellung von immunotestverfahren | |
DK1025083T3 (da) | Fremgangsmåde til stereoselektiv syntese af prostacyclin-derivater | |
DE59812529D1 (de) | Monoklonaler Antikörper 4G8B4B12 gegen humanes FLT3/FLK2 | |
DE69328779D1 (de) | Benzodiazepin-derivate sowie deren konjugate mit proteinen und polypeptiden | |
AU7714294A (en) | Reagents and methods for the detection and quantification of testosterone in fluid samples | |
CA2062820A1 (en) | Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates | |
EP0824104A3 (en) | Immunoassay method | |
AU5173996A (en) | Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels | |
BR9712220A (pt) | Processo de sincronização grosseira de um receptor com um transmissor, sistema de comunicação, e, receptor sincronizável com um transmissor. | |
NO993180L (no) | N-(pyridinylamino)isoindoler og beslektede forbindelser |